Filing Details

Accession Number:
0001209191-15-081661
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-11-20 17:27:22
Reporting Period:
2015-11-18
Filing Date:
2015-11-20
Accepted Time:
2015-11-20 17:27:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
821995 Juniper Pharmaceuticals Inc JNP Pharmaceutical Preparations (2834) 592758596
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1587273 Nikin Patel C/O Juniper Pharmaceuticals, Inc.
Four Liberty Square
Boston MA 02109
Coo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.01 Acquisiton 2015-11-18 700 $11.45 185,084 No 4 P Direct
Common Stock, Par Value $0.01 Acquisiton 2015-11-19 4,300 $11.88 189,384 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. This transaction was executed in a single trade at a price of $11.452. The price reported reflects the weighted-average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range described above.
  2. This transaction was executed in a single trade at a price of $11.884. The price reported reflects the weighted-average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range described above.